1. INNV-09. IMPACT OF MOLECULAR MARKERS ON TREATMENT OUTCOME OF GLIOBLASTOMA PATIENTS TREATED WITH CONCURRENT TUMOR-TREATING FIELDS (TTF) AND CHEMORADIATION: SECONDARY ANALYSIS OF SPARE TRIAL. (14th November 2022) Authors: Cappelli, Louis; Kayne, Allison; Poiset, Spencer; Niazi, Muneeb; Ali, Ayesha; Alnahhas, Iyad; Shi, Wenyin Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. RADT-19. CHEMORADIATION (CRT) TREATMENT WITH OR WITHOUT CONCURRENT TUMOR-TREATING FIELDS (TTFIELDS) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM). (14th November 2022) Authors: Cappelli, Louis; Kayne, Allison; Pan, Peter; Cordova, James; Huang, Jiayi; Wang, Tony; Alnahhas, Iyad; Shi, Wenyin Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Single-Dose Radiation Therapy Without Additional Surgery as a Treatment for Heterotopic Ossification Developing After Transfemoral Amputation. (2nd November 2022) Authors: Zorn, Devon; Lombardo, Joseph; Poiset, Spencer; Gutman, Michael; Cappelli, Louis; Hurwitz, Mark; Ankam, Nethra Journal: American journal of physical medicine & rehabilitation Issue: Volume 101:Number 11(2022) Page Start: e158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗